FARAWAVE Wins Award
2025-10-15 07:19:24

Boston Scientific Japan's FARAWAVE Catheter Wins 2025 Good Design Award

Boston Scientific Japan's FARAWAVE Catheter: A Design Revolution in Medical Technology



Boston Scientific Japan has announced that its innovative FARAWAVE™ catheter has been awarded the prestigious 2025 Good Design Award, hosted by the Japan Design Promotion Association. This award recognizes the product’s exceptional industrial design, particularly its user-friendliness in medical settings.

About the FARAWAVE™ Catheter


The FARAWAVE catheter is a critical component of the FARAPULSE™ pulse field ablation (PFA) system, specifically designed for the treatment of atrial fibrillation (AF). Atria fibrillation is a common heart condition that can lead to serious complications if not adequately managed. Operating efficiently is paramount in the medical field, and the design of this catheter focuses on enhancing procedural efficiency, visibility, and stability during usage. The approval number for this medical device is 30600BZX00197000.

Highlights of the Award-Winning Product:


  • - Product Name: FARAWAVE™ PFA Catheter
  • - Purpose: Utilized in catheter ablation techniques for pulmonary vein isolation in AF treatment.

The design philosophy prioritizes ideal operational rhythms, ensuring that the shape and functionalities of the catheter do not disrupt the sequence of medical procedures.

Commitment to Innovation


In a statement regarding this prestigious recognition, Tomoyuki Morikawa, the President and CEO of Boston Scientific Japan, expressed, _“This award reflects our ongoing commitment to developing safer and more effective treatments for patients.”_ He further emphasized that the FARAPULSE PFA system is the culmination of innovations designed with healthcare professionals' insights in mind.

Judging Panel's Remarks


The panel lauded the FARAWAVE catheter for offering groundbreaking solutions in atrial fibrillation treatment. Traditional methods that rely on heat can pose safety challenges; however, the use of electrical pulses in the FARAWAVE catheter targets only cardiac tissue, significantly improving safety and efficiency. The design offers exceptional usability, reliability, and visibility—all critical factors in medical applications. These attributes are underpinned by Boston Scientific's extensive experience in science and technology, consistently integrated into their product designs with utmost care.

Upcoming Exhibition


The FARAWAVE catheter will be showcased at the upcoming GOOD DESIGN EXHIBITION 2025, which will take place from November 1st to 5th at Tokyo Midtown in Roppongi. For further information, please visit the official Good Design Award website at Good Design Award.

About the Good Design Award


Established in 1957, the Good Design Award originates from a system that evaluates and recommends outstanding designs across various domains including products, architecture, software, and services, with a focus on improving societal quality of life. The award symbolizes exceptional design through the widely recognized G-Mark.

Company Overview: Boston Scientific


Boston Scientific is dedicated to advancing patient care through innovative medical solutions that enhance the health of patients globally. As a leader in medical technology for over 40 years, the company aims to address unmet patient needs while reducing healthcare costs through high-performance solutions. Their commitment spans various fields including cardiovascular, arrhythmia, and gastrointestinal disorders, ensuring significant contributions to the wellbeing of patients in Japan and beyond.

For more information, visit Boston Scientific Japan.


画像1

画像2

画像3

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.